The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...
With the announcement of this new FDA-approved pain medication comes a new class of pain relief that bypasses these dangers. Unlike opioids, which work by dulling pain perception in the brain ...
The drug, called Journavx (suzetrigine) and manufactured by biotech company Vertex Pharmaceuticals, is a non-opioid painkiller, which doesn’t have addictive properties, unlike opioids often used for ...